Prostate cancer continues to be a significant health problem for men. New tests offer new opportunities for early recognition and evolving treatment modalities offer new hope. This activity will examine the changing face of prostate cancer from detection through treatment.
Register now for this one-day CME conference. Join us in Rancho Mirage, California, for this exciting conference with some of the country's top experts.
Conference Program:

Saturday Morning, March 31, 2007
7:00-8:00 Breakfast  
8:00-8:10 Program Welcome and Introduction to Session I  
Session I Early Detection and Chemoprevention Peter Carroll, MD
8:10-8:30 Chemoprophylaxis and Prevention William Aronson, MD
8:30 -8:50 PSA and Beyond Anthony D'Amico, MD, PhD
8:50-9:10 The Roles Of Biopsy And Imaging William Aronson, MD
Session II Changing Demographics and Risk
Assessment in Prostate Cancer 		 
9:10-9:30 Changing Demographics and Risk in Prostate Cancer Peter Carroll, MD
9:30-9:50 Break  
9:50-10:10 Overall Staging and Risk Assessment of Disease Anthony D'Amico, MD, PhD
10:10-10:30 New Biologic Markers for Risk Assessment Philip Kantoff, MD
10:30-10:50 Overdetection and Treatment -
a Rationale for Active Surveillance?		 Peter Carroll, MD
10:50-11:20 Panel Discussion — Health-Related Quality of Life Issues - What Matters Most to Patients? Moderator: Anthony D'Amico, MD, PhD
Session III Treatment Modalities -
Low, Intermediate and High Risk Disease		 Peter Carroll, MD
11:20-11:40 Radiation Therapy for Prostate Cancer: Brachytherapy, IMRT or Both? Brian Moran, MD
11:40-12:00 Debate:
Pros and Cons - Conventional or Robotic Assisted Minimally Invasive Surgery?		 William Aronson, MD and Peter Carroll, MD
12:00-1:00 Lunch  
Saturday Afternoon, March 31, 2007
1:00-1:40 Case Studies, Short Presentations, and Panel
Discussion on Low to Intermediate Risk Disease		 Moderator: John Stevenson, MD
Panel:
Brian Moran, MD
William Aronson, MD
Philip Kantoff, MD
Anthony D'Amico, MD
1:40 -2:00 Definition and Multimodal Management of
High-Risk Disease		 Philip Kantoff, MD
2:00-2:20 Hormonal Therapy: Timing, Type And Symptom Management Daniel Petrylak, MD  
2:20-3:00 Case Studies, Short Presentations, and Panel Discussion on High Risk Disease Moderator: Philip Kantoff, MD
Panel:
Brian Moran, MD
William Aronson, MD
Daniel Petrylak, MD
Anthony D'Amico, MD
3:00-3:20 Break  
3:20-3:40 Initial Assessment and Management of Biochemical
Failure and Hormone-Resistant Relapsed Disease		 Philip Kantoff, MD
Session IV Future Directions  
3:40-4:00 Developmental Therapeutics and Clinical Trial Data Daniel Petrylak, MD
4:00-4:30 Case-Based Panel Discussion and Q&A:
What Does The Future Hold?		 Moderator: Peter Carroll, MD
4:30-4:40 Closing Remarks And Adjournment Peter Carroll, MD and John Stevenson, MD
4:45 - 6:30 Reception  

Copyright 2007
Annenberg Center for Health Sciences
at Eisenhower